Who has invested in Enalare Therapeutics?

Eagle Pharmaceuticals are named among the investors backing Enalare Therapeutics.

Enalare Therapeutics Funding: $65M Raised, Seed (2022)

Enalare Therapeutics funding overview

Enalare Therapeutics is based in Princeton, New Jersey. Enalare Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in October 2022. The round record for Enalare Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Eagle Pharmaceuticals.

Enalare Therapeutics at a glance

Total raised: $65M
Latest round: Seed
Latest round date: October 2022
Headquarters: Princeton, New Jersey
Notable investors: Eagle Pharmaceuticals

Frequently asked about Enalare Therapeutics funding

How much has Enalare Therapeutics raised?: Enalare Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Enalare Therapeutics?: Eagle Pharmaceuticals are named among the investors backing Enalare Therapeutics.
What was the latest Enalare Therapeutics funding round?: The most recent disclosed round is a Seed, announced in October 2022.
Where is Enalare Therapeutics based?: Enalare Therapeutics is based in Princeton, New Jersey.
When did Enalare Therapeutics last raise?: The last disclosed Enalare Therapeutics round closed in October 2022 at Seed.

We update the Enalare Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Princeton and their backers are listed below.

Enalare Therapeutics Funding: $65M Raised, Seed (2022)

Enalare Therapeutics funding overview

Enalare Therapeutics at a glance

Frequently asked about Enalare Therapeutics funding

Companies related to Enalare Therapeutics (13)

Browse related funding lists (3)